Trial Profile
Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Bile duct diseases; Crohn's disease; Malabsorption syndromes
- Focus Therapeutic Use
- Acronyms COBAM
- 01 Mar 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 01 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jun 2012 Other source identified and integrated: European Clinical Trials Database record EudraCT2009-010727-91.